Investigating how G protein signaling affects brain injury recovery
G Protein Signaling in Brain Injury
This study is looking at how a protein called RIT2 affects brain cell damage and problems after a traumatic brain injury, using mice to find new ways to help people recover better from such injuries.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-10626681 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of a specific G-protein, RIT2, in the processes that lead to neuronal death and dysfunction following traumatic brain injury (TBI). By using mouse models, the researchers aim to uncover how RIT2 influences neurodegeneration and metabolic dysfunction after brain injuries. The study will explore innovative therapeutic approaches that could potentially mitigate the damage caused by TBI and improve recovery outcomes for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced a traumatic brain injury and are facing challenges related to neuronal dysfunction.
Not a fit: Patients with non-traumatic brain injuries or those who do not have significant neuronal dysfunction may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that enhance neuronal survival and recovery after traumatic brain injuries.
How similar studies have performed: Previous research has shown promise in targeting G-protein signaling pathways for neuroprotection, suggesting that this approach may yield beneficial results.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Andres, Douglas Allen — University of Kentucky
- Study coordinator: Andres, Douglas Allen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.